Davis Andrew 4
4 · IRONWOOD PHARMACEUTICALS INC · Filed May 24, 2023
Insider Transaction Report
Form 4
Davis Andrew
SVP, Chief Business Officer
Transactions
- Sale
Class A Common Stock
2023-05-22$10.12/sh−6,305$63,807→ 219,327 total
Footnotes (1)
- [F1]The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.